blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2205595

EP2205595 - OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.07.2015
Database last updated on 03.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): LU, TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2010/28]
Inventor(s)01 / KWAK, Young-Shin
58 Blossomcrest Road
Lexington MA 02421 / US
02 / COPPOLA, Gary Mark
18 Aldersgate Circle
Budd Lake New Jersey 07828 / US
 [2010/28]
Representative(s)Campbell, Lachlan Clive, et al
Novartis Pharma AG
Lichtstrasse 35
4056 Basel / CH
[2014/09]
Former [2014/07]Campbell, Lachlan Clive, et al
Novartis Pharma AG
Patent Department
Forum 1
Novartis Campus
4056 Basel / CH
Former [2010/28]Vögeli-Lange, Regina, et al
Novartis Pharma AG Patent Department
4002 Basel / CH
Application number, filing date08804779.026.09.2008
[2010/28]
WO2008EP62900
Priority number, dateUS20070976064P28.09.2007         Original published format: US 976064 P
[2010/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009040410
Date:02.04.2009
Language:EN
[2009/14]
Type: A1 Application with search report 
No.:EP2205595
Date:14.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application.
[2010/28]
Type: B1 Patent specification 
No.:EP2205595
Date:10.09.2014
Language:EN
[2014/37]
Search report(s)International search report - published on:EP02.04.2009
ClassificationIPC:C07D413/04, C07D413/14, A61K31/42, A61K31/4245, A61K31/44, A61P3/00
[2010/28]
CPC:
C07D413/04 (EP,US); A61P1/14 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P17/00 (EP); A61P17/10 (EP);
A61P19/06 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D413/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/28]
Extension statesAL28.04.2010
BA28.04.2010
RS28.04.2010
TitleGerman:OXADIAZOL- UND OXAZOL-SUBSTITUIERTE BENZIMIDAZOL- UND INDOL-DERIVATE ALS DGAT1-HEMMER[2010/28]
English:OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS[2010/28]
French:DÉRIVÉS DE BENZIMIDAZOLE ET D'INDOLE SUBSTITUÉS PAR DE L'OXADIAZOLE ET OXAZOLE COMME INHIBITEURS DE DGAT1[2010/28]
Entry into regional phase28.04.2010National basic fee paid 
28.04.2010Designation fee(s) paid 
28.04.2010Examination fee paid 
Examination procedure28.04.2010Examination requested  [2010/28]
07.06.2010Amendment by applicant (claims and/or description)
11.07.2012Despatch of a communication from the examining division (Time limit: M04)
15.11.2012Reply to a communication from the examining division
15.01.2013Despatch of a communication from the examining division (Time limit: M04)
23.05.2013Reply to a communication from the examining division
14.11.2013Communication of intention to grant the patent
14.03.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
03.04.2014Communication of intention to grant the patent
28.07.2014Fee for grant paid
28.07.2014Fee for publishing/printing paid
28.07.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.07.2012
Opposition(s)11.06.2015No opposition filed within time limit [2015/34]
Fees paidRenewal fee
14.09.2010Renewal fee patent year 03
30.09.2011Renewal fee patent year 04
12.09.2012Renewal fee patent year 05
12.09.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.09.2008
AT10.09.2014
BE10.09.2014
BG10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
MT10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
TR10.09.2014
IE26.09.2014
LU26.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
[2016/33]
Former [2016/32]HU26.09.2008
AT10.09.2014
BE10.09.2014
BG10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
MT10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
IE26.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2016/28]AT10.09.2014
BG10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
MT10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
IE26.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2016/25]AT10.09.2014
BG10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
IE26.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/50]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
IE26.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/37]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
IE26.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/34]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/33]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
BE30.09.2014
CH30.09.2014
LI30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/32]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
BE30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/30]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
BE30.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/25]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/24]CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/23]CY10.09.2014
CZ10.09.2014
EE10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/22]CY10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
RO10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
PT12.01.2015
Former [2015/16]CY10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/12]CY10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/11]CY10.09.2014
FI10.09.2014
LT10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/10]FI10.09.2014
LT10.09.2014
SE10.09.2014
NO10.12.2014
Former [2015/09]FI10.09.2014
LT10.09.2014
SE10.09.2014
Former [2015/08]LT10.09.2014
Cited inInternational search[A]WO2006134317  (ASTRAZENECA AB [SE], et al) [A] 1-32 * the whole document *;
 [A]US2005070545  (FOX BRIAN M [US], et al) [A] 1-32 * the whole document *;
 [A]WO2004100881  (BAYER PHARMACEUTICALS CORP [US], et al) [A] 1-32 * the whole document *
ExaminationWO2005121132
by applicantWO2006134317
    - CASES ET AL., PROC. NATL. ACAD. SCI., (1998), vol. 95, pages 13018 - 13023
    - CASES ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 38870 - 38876
    - SMITH ET AL., NATURE GENETICS, (2000), vol. 25, pages 87 - 90
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.